Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1

Status

Completed 4Terminated 2Unknown 1Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4

Conditions

Leukemia, Myeloid, Acute 1540Leukemia 1389Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Leukemia, Lymphocytic, Chronic, B-Cell 1090Myelodysplastic Syndromes 722Lymphoma 658Lymphoma, Non-Hodgkin 627Hematologic Neoplasms 556Lymphoma, Follicular 487Leukemia, Myelogenous, Chronic, BCR-ABL Positive 470Lymphoma, Mantle-Cell 459Lymphoma, Large B-Cell, Diffuse 444Burkitt Lymphoma 432Hodgkin Disease 431Lymphoma, B-Cell, Marginal Zone 424Multiple Myeloma 415Lymphoma, Large-Cell, Immunoblastic 335Leukemia, Myelomonocytic, Chronic 314Congenital Abnormalities 287Recurrence 279Leukemia, Myeloid, Chronic-Phase 272Myeloproliferative Disorders 260Neoplasms 256Blast Crisis 250Waldenstrom Macroglobulinemia 232Leukemia, Myeloid, Accelerated Phase 217Lymphoma, T-Cell, Cutaneous 213Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Mycosis Fungoides 183Lymphoma, Large-Cell, Anaplastic 181

Interventions

Pharmacogenomic Testing 1Nivolumab 1Daclizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × HTLV-I Infections × Other hematologic neoplasm × Clear all
NCT02631746 2025-03-14

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
3 enrolled 8 charts
LymphoidOther hematologic neoplasm

Lymphoma, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03226119 2018-09-13

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

MP Biomedicals, LLC

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT03146013 2017-06-12

Dual Algorithm Post Market Clinical Study

MP Biomedicals, LLC

Completed
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT00001941 2012-08-20

Anti-Tac for Treatment of Leukemia

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
34 enrolled 12 charts
LymphoidOther hematologic neoplasm

Diabetes Mellitus, Insulin-Dependent, 10, Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡